Abstract
There is growing appreciation for the importance of non-protein-coding genes in development and disease. Although much is known about microRNAs, limitations in bioinformatic analyses of RNA sequencing have precluded broad assessment of other forms of small-RNAs in humans. By analysing sequencing data from plasma-derived RNA from 40 individuals, here we identified over a thousand human extracellular RNAs including microRNAs, piwi-interacting RNA (piRNA), and small nucleolar RNAs. Using a targeted quantitative PCR with reverse transcription approach in an additional 2,763 individuals, we characterized almost 500 of the most abundant extracellular transcripts including microRNAs, piRNAs and small nucleolar RNAs. The presence in plasma of many non-microRNA small-RNAs was confirmed in an independent cohort. We present comprehensive data to demonstrate the broad and consistent detection of diverse classes of circulating non-cellular small-RNAs from a large population.
Introduction
For years, the study of extracellular RNAs (exRNAs) in human plasma was almost synonymous with microRNAs (miRNAs). While miRNAs are vital regulators of gene expression, they represent only a fraction of the small-RNA landscape. Other classes, such as piwi-interacting RNAs (piRNAs) and small nucleolar RNAs (snoRNAs), were suspected to circulate but remained difficult to characterize due to bioinformatic hurdles and low abundance. This study aimed to determine if these diverse small RNAs are consistently present across large populations and whether their levels correlate with human phenotypes like age, sex, or cardiovascular risk.
Methods
The researchers employed a robust two-stage discovery and validation approach. Initially, small-RNA sequencing was performed on plasma from 40 participants of the Framingham Heart Study (FHS) Offspring Cohort using the Ion Proton platform. To navigate the complexity of the resulting data, a specialized bioinformatic pipeline called exceRpt was utilized. This pipeline is designed to filter out contaminants and map reads sequentially to various small-RNA libraries, including miRBase, tRNA, piRNA, and the host genome.
Following discovery, high-throughput quantitative PCR (Fluidigm BioMark) was used to validate 485 specific transcripts in a massive cohort of 2,763 individuals. Biochemical confirmation of piRNAs was achieved through sodium periodate treatment, which selectively degrades unmodified RNAs while leaving the 2’-O-methylated 3’ ends of piRNAs intact.
Key Results and Insights
The study revealed that the "extracellular RNA-ome" is far more diverse than previously thought. While two specific miRNAs (miR-223-3p and miR-451a) dominate the plasma RNA pool, the remaining sequences contain over a thousand diverse RNA species.
Consistency Across Populations
A critical finding was the consistency of these non-miRNA species. They are not merely random cellular "leakage." The data showed that 50% of the population carried a consistent "core" set of at least 11 snoRNAs and 20 piRNAs. In the large validation cohort, the researchers successfully characterized the distribution of 331 miRNAs, 97 piRNAs, and 43 snoRNAs.
Phenotype Associations
One of the most striking observations was the correlation between exRNA levels and age. Approximately 39% of miRNAs, 13% of piRNAs, and 21% of snoRNAs were associated with age, generally showing lower abundance in older individuals (over 66.5 years). This suggests that the extracellular RNA profile undergoes predictable changes during aging. Interestingly, few RNAs showed strong correlations with sex or specific cardiovascular risk scores in this cohort.
Discussion and Future Directions
This work establishes that diverse classes of small RNAs are stable, detectable features of human plasma. However, several questions remain. The Framingham Heart Study cohort is primarily of European descent and older; future research must validate these profiles in more diverse and younger populations.
Furthermore, the functional roles of these circulating piRNAs and snoRNAs remain a mystery. Whether they act as signaling molecules in cell-to-cell communication or are simply stable byproducts of cellular processes is yet to be determined. Identifying the tissue of origin for these transcripts could also unlock their potential as powerful, organ-specific biomarkers for various diseases.
Summary updated